Jostein Davidsen has been a board member in Navamedic since January 2017.Jostein brings more than 30 years of experience from the international pharmaceuticals industry, most recently serving as the Chief Executive Officer of the Acino Pharmaceuticals in Switzerland.
He previous founded NYCOMED Russia – CIS, that become one of the top leaders on the Russian – CIS pharmaceutical markets, which grew to over 1500 employees including local manufacturing in 2011 before Nycomed Pharma was acquired by Takeda Pharmaceuticals.
He served after the transaction as a Corporate Officer and the Head of the Emerging Markets at Takeda Pharmaceuticals International based in Zurich Switzerland. He was during this time named the world’s second most influential pharma-industry leader in Emerging Markets by Scrip (the pharmaceutical international news journal).
Davidsen studied Business and Administration at Handelsakademiet in Oslo and have completed several Executive Management Programs and Board learning program at IMD, Lausanne Switzerland.